- JP-listed companies
- Astellas Pharma Inc.
- Balance sheet
Astellas Pharma Inc.【JP:4503】Balance sheet
Market cap
¥4.05T
P/E ratio
22.3x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 13,012 | 60,027 | 96,791 | 93,165 | 311,074 | 318,391 | 326,128 | 315,986 | 376,840 | 335,687 | 188,372 |
| Marketable securities, current | - | 91,530 | 12,024 | 8,000 | 2,000 | 2,607 | 9,459 | 5,560 | 21,297 | 19,784 | 28,784 | 29,941 |
| Inventories | - | 81,468 | 83,272 | 97,548 | 54,001 | 151,511 | 151,017 | 164,080 | 153,072 | 174,386 | 248,738 | 297,261 |
| Total current assets | - | 472,791 | 479,585 | 480,999 | 452,378 | 857,159 | 867,514 | 872,588 | 923,354 | 1,049,954 | 1,194,730 | 1,201,349 |
| Property, plant and equipment, net | - | 79,133 | 74,022 | 72,170 | 70,662 | 173,483 | 268,600 | 264,623 | 269,044 | 286,459 | 293,742 | 328,921 |
| Marketable securities, non-current | - | 68,476 | 51,868 | 29,985 | 33,415 | 81,457 | 74,264 | 95,850 | 91,844 | 97,886 | 108,694 | 106,195 |
| Total non-current assets | - | 579,991 | 622,577 | 641,832 | 731,268 | 1,040,489 | 1,450,646 | 1,401,040 | 1,409,041 | 1,406,564 | 2,374,873 | 2,138,195 |
| Total assets | - | 1,052,782 | 1,102,161 | 1,122,830 | 1,858,205 | 1,897,648 | 2,318,160 | 2,273,628 | 2,332,395 | 2,456,518 | 3,569,603 | 3,339,544 |
| Short-term debt | - | 60,677 | 293,643 | 378,070 | 366,583 | 14,136 | 345,707 | 148,163 | 184,964 | 180,131 | 97,565 | 20,144 |
| Long-term debt, current | - | - | - | - | - | - | - | - | - | 75,000 | 472,278 | 266,533 |
| Total current liabilities | - | 306,023 | 521,964 | 572,733 | 538,718 | 497,665 | 798,708 | 592,372 | 687,411 | 726,034 | 1,285,725 | 1,061,610 |
| Long-term debt, non-current | - | - | - | - | - | - | - | 80,000 | - | 189,924 | 553,340 | 671,652 |
| Total non-current liabilities | - | 5,316 | 29,468 | 35,488 | 32,549 | 141,587 | 230,284 | 295,141 | 184,676 | 222,530 | 687,889 | 764,679 |
| Total liabilities | - | 311,340 | 551,432 | 608,221 | 589,916 | 639,252 | 1,028,992 | 887,513 | 872,087 | 948,564 | 1,973,615 | 1,826,289 |
| Common stock and paid-in capital | - | 279,823 | 279,823 | 279,823 | 560,043 | 560,125 | 560,330 | 560,654 | 562,291 | 564,104 | 566,894 | 568,083 |
| Retained earnings | - | 516,511 | 405,042 | 362,061 | 454,719 | 991,957 | 905,851 | 953,289 | 944,261 | 908,158 | 809,400 | 740,939 |
| Stockholders' equity | 820,086 | 741,442 | 550,729 | 514,609 | 612,379 | 1,258,396 | 1,289,168 | 1,386,115 | 1,460,308 | 1,507,954 | 1,595,988 | 1,513,255 |